References:
[1] Naris, S., 2022, Significant Role of Free Radicals in Diabetes Mellitus. Oxidants and Antioxidants in Medical Science. Oxidants and Antioxidants in Medical Science, 11(8), 1-2.
[2] Drummond, G. R., Selemidis, S., Griendling K., & Sobey, C. G., 2011, Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Reviews Drug Discovery, 10(6),453–471. doi: 10.1038/nrd3403.
[3] Johansen, J., Harris, A. K., Rychly, D. J., & Ergul, A., 2005, Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovascular Diabetology,4(1), p. 5. doi: 10.1186/1475-2840-4-5.
[4] Pacher, P., Beckman, J. S., & Liaudet, L., 2007, Nitric oxide and peroxynitrite in health and disease. Physiological Reviews, 87(1),315–424. doi: 10.1152/physrev.00029.2006.
[5] Zhang, D. X., & Gutterman, D.D., 2007, Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology, 292(5), H2023–H2031. doi: 10.1152/ajpheart.01283.2006.
[6] Goldstein, B.J., Mahadev, K., Wu, X., Zhu, L., & Motoshima, H., 2005, Role of Insulin-Induced Reactive Oxygen Species in the Insulin Signaling Pathway. Antioxid Redox Signal, 7(7-8), 1021–1031. doi: 10.1089/ars.2005.7.1021.
[7] Harsha, L., & Subramanian, A. K., 02022, Comparative Assessment of pH and Degree of Surface Roughness of Enamel When Etched with Five Commercially Available Etchants: An In Vitro Study. The Journal of Contemporary Dental Practice, 23(2), 181–185.
[8] Nrf2. 2021, The IUPHAR/BPS Guide to Pharmacology. https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2605&familyId=694&familyType=TF.
[9] He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X., 2017, Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cellular Physiology and Biochemistry, 44(2),532-553. doi: 10.1159/000485089.91.
[10] Antonyuk, S.V., Strange, R.W., Marklund, S.L., & Hasnain, S.S., 2009, The Structure of Human Extracellular Copper-Zinc Superoxide Dismutase at 1.7 A Resolution: Insights into Heparin and Collagen Binding. Journal of Molecular Biology, 388, 310. PubMed: 19289127. DOI: https://doi.org/10.1016/j.jmb.2009.03.026.
[11] Eletsky, A., Pulavarthi, S.V.S.R.K., Lee, D., Kohan, E., Janjua, H., Xiao, R., Acton, T.B., Everette, J.K., Montelione, G.T., & Szyperski, T., 2012, Solution NMR Structure of the DNA-Binding Domain of Human NF-E2-Related Factor 2, Northeast Structural Genomics onsortium(NESG)TargetHR3520O. https://doi.org/10.2210/pdb2LZ1/pdb.
[12] Kavanagh, K.L., Johansson, C., Smee, C., Gileadi, O., Von Delft, F., & Oppermann,U., 2005, Crystal structure of the selenocysteine to glycine mutant of human glutathione peroxidase 1. https://doi.org/10.2210/pdb2F8A/pdb.
[13] Pilka, E.S., Kavanagh, K.L., Cooper, C., von Delft, F., Sundstrom, M., Arrowsmith, C.A., Weigelt, J., Edwards, A., & Oppermann, U., 2007, Crystal structure of human peroxiredoxin 4 (thioredoxin peroxidase). https://doi.org/10.2210/pdb2PN8/pdb
[14] Neralla, M., M, H., Preethi, A., Selvakumar, S. C., & Sekar, D., 2024, Expression levels of microRNA-7110 in oral squamous cell carcinoma. Minerva dental and oral science, 73(3), 155–160. https://doi.org/10.23736/S2724-6329.23.04801-5.
[15] Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, & D. S. and Olson, A. J., 2009, Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. Journal of Computational Chemistry,16, 2785-2791.
[16] Smith, J. A., & Park, S., 2021, Superoxide Dismutase 1 (SOD1). In Handbook of Amyotrophic Lateral Sclerosis, (pp. 19-31), Springer.
[17] Younus, H., 2018, Therapeutic potentials of superoxide dismutase. International Journal of Health Sciences (Qassim). 12(3): 88-93.
[18] Lei, X.G., Zhu, J.H., Cheng, W.H., Bao, Y., Ho, Y.S., Reddi, A.R., Holmgren, A., & Arnér, E.S., 2016, Paradoxical roles of antioxidant enzymes: basic mechanisms and health implications. Physiol Rev, 96:307–364. DOI: 10.1152/physrev.00010.2014.
[19] Lewis, P., Stefanovic, N., Pete, J., Calkin, A.C., Giunti, S., Thallasbonke, V., Jandeleitdahm, K.A., Allen, T.J., Kola, I., & Cooper, M.E., 2007, Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E–deficient mice. Circulation, 115,2178–2187. doi: 10.1161/CIRCULATIONAHA.106.664250.
[20] Ramalingam, K., Yadalam, P. K., Ramani, P., Krishna, M., Hafedh, S., Badnjević, A., Cervino, G., & Minervini, G., 2024, Light gradient boosting-based prediction of quality of life among oral cancer-treated patients. BMC Oral Health, 24(1), 349. https://doi.org/10.1186/s12903-024-04050-x.
[21] Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., & Yamamoto, M., 2008, Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Molecular and Cellular Biology, 28,2758–2770. doi: 10.1128/MCB.01704-07.
[22] Stancill, J.S., & Corbett, J.A., 2021, The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage.Front Endocrinol (Lausanne),12,718235. doi: 10.3389/fendo.2021.718235.
[23] Elmarakby, A.A., Faulkner, J., Baban, B., & Sullivan, J.C., 2012, Induction of Hemeoxygenase-1 Reduces Renal Oxidative Stress and Inflammation in Diabetic Spontaneously Hypertensive Rats. International Journal of Hypertension, 957235. doi:10.1155/2012/957235.
[24] Elmarakby, A.A., Faulkner, J., Baban, B., Saleh, M.A., & Sullivan, J.C., 2012, Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. American Journal of Physiology-Renal Physiology, 302(7), F791–F800. doi: 10.1152/ajprenal.00472.2011: 10.1152/ajprenal.00472.2011.